Clinical trials
Phase 2 Leukemia trials with unknown status
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
35 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2001 | 2 |
| 2002 | 1 |
| 2003 | 2 |
| 2004 | 1 |
| 2005 | 2 |
| 2006 | 1 |
| 2007 | 3 |
| 2008 | 3 |
| 2009 | 2 |
| 2010 | 1 |
| 2011 | 2 |
| 2016 | 1 |
| 2019 | 2 |
| 2020 | 1 |
| 2022 | 1 |
| 2023 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Unknown status | 35 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Jonsson Comprehensive Cancer Center | 3 |
| Herbert Irving Comprehensive Cancer Center | 2 |
| ALZA | 1 |
| Armaceutica, Inc. | 1 |
| Auxilio Mutuo Cancer Center | 1 |
| Chronic Lymphocytic Leukemia Research Consortium | 1 |
| Colorado Blood Cancer Institute | 1 |
| European Organisation for Research and Treatment of Cancer - EORTC | 1 |
| Fundación Teófilo Hernando, Spain | 1 |
| Great Ormond Street Hospital for Children NHS Foundation Trust | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Leukemia | 35 |
| Leukemia, Myeloid, Acute | 13 |
| Precursor Cell Lymphoblastic Leukemia-Lymphoma | 12 |
| Lymphoma | 11 |
| Leukemia, Lymphocytic, Chronic, B-Cell | 10 |
| Myelodysplastic Syndromes | 10 |
| Leukemia, Myeloid, Chronic-Phase | 8 |
| Multiple Myeloma | 8 |
| Burkitt Lymphoma | 7 |
| Lymphoma, Follicular | 7 |
Trials
Showing 1 to 25 of 35. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.